First-time prescriptions for Eli Lilly’s Zepbound surpassed those for Novo Nordisk’s Wegovy in early March, according to data cited by Reuters.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
Zepbound surpasses Wegovy in new prescriptions: Reuters
